Louis Villalba was previously with OvaScience where he served as Executive Vice President of Corporate Development and brings more than 25 years of industry experience in developing and commercialising innovative therapies. Prior to OvaScience, Mr. Villalba was Chief Business Officer at Evofem, Global Vice President of Sales at Auxogyn and Executive Vice president of Europe for Conceptus where he was part of the team that completed the $1.1B sale of the company to Bayer AG. Louis earned a B.A. in Business Management at Menlo College.

Dr Robert Woolcott is one of Australia’s most experienced fertility specialists having practiced Fertility based medicine for over 25 years, performing over 10,000 IVF procedures and being the author of numerous peer-reviewed journal articles. In addition to this role, he is also a Director for Genea.

With over 25 years’ experience within Pharmaceutical and Medical Device manufacturing environments. Mike has a proven track record of successfully managing new product introductions within a number of “blue chip” companies. Mike, who joined Genea Biomedx in August 2015 works out of our Sandwich site based in the UK. He is responsible for the operations of both our Australia and UK facilities.

Bekezela Ngwenya has over 15 years of experience in quality assurance in the pharmaceutical and medical devices industries. She has a proven track record in establishing and maintaining quality management systems and is experienced in ensuring compliance with local and international standards. She is responsible for ensuring the quality and compliance of products manufactured by Genea Biomedx. Bekezela holds a Bachelor of Science in Applied Chemistry and a Masters of Business and Technology.